Compositions and methods of targeting mutant K-ras
申请人:NANTBIO, INC.
公开号:US10344026B2
公开(公告)日:2019-07-09
Compounds and compositions are presented that inhibit K-Ras, and especially mutant K-Ras. Certain compounds preferentially or even selectively inhibit specific forms of mutant K-Ras, and particularly the G12D mutant form.